Fig. 2
From: Impact of polypharmacy on 3-year mortality in patients with heart failure: a retrospective study
Primary and secondary endpoints by number of GDMT and ni-GDMT drugs. Primary endpoint: Kaplan-Meier curve for all-cause mortality (A); secondary endpoints: cumulative incidence of cardiac death due to shock, heart failure, arrhythmia, and myocardial infarction (B); cumulative incidence of other noncardiac death (C)